• March 22, 2013
    Zoetis, formerly Pfizer Animal Health, announces the return of the Cattle Call grant program and is accepting research proposals for improving cattle reproduction or developing models for managing cattle pain. The Cattle Call supports the development of new products and services that improve the health and productivity of beef and dairy cattle. In 2013, Zoetis will fund one or more researchers with a grant of up to $150,000, withmore...
  • October 3, 2012
    Pfizer Animal Health announces the launch of Poulvac E coli, the first spray vaccine against avian pathogenic Escherichia coli (APEC) for the poultry industry to be approved in the European Union. This new vaccine is based on a European E. coli isolate, and has been shown to provide a broad protection against field infections found in the region. It can be administered from one day of age, and studies have shown that it generates amore...
  • April 13, 2012
    PARIS, France--Four European academic research groups, together with Pfizer Animal Health, have forged a new research consortium to combat uterine disease - a problem that costs the EU dairy industry about €1.4billion annually. Called the IPUD research project (Integrated systems approach for Preventing Uterine Disease in dairy cattle), the collaboration involves academic research groups at Swansea University, the University ofmore...
  • April 11, 2012
    RALEIGH, N.C.--Poultry science students at the University of Arkansas have been awarded a $3,000 grant for their initiative which aims to improve the public’s understanding of the poultry industry. The award is courtesy of Reach Teach Learn―a Pfizer Animal Health Global Poultry project―which invited agriculture students across the U.S. to demonstrate how they could open a dialogue with consumers and enhance the perception of the poultrymore...
  • February 27, 2012
    MADISON, N.J.--Fostera™ PRRS*, a modified-live vaccine for growing pigs from Pfizer Animal Health, brings a new high standard of innovation to the costly battle against porcine reproductive and respiratory syndrome (PRRS) respiratory disease. Demonstrating its commitment to high standards, Pfizer Animal Health's research and development team made a significant breakthrough. They created unique cell lines that were able to express amore...
  • January 25, 2012
    DURHAM, N.C.--Pfizer Animal Health Global Poultry’s new in ovo vaccination device, which was officially unveiled at IPE, could help improve operations at smaller hatcheries, according to one of the device’s trial participants. Marciano Régis Tonus, agribusiness director of Frango Seva, in Pato Branco, Brazil, spent a month trialling the new Embrex® Inovoject® m, a semi-automated device designed specifically for hatcheries that do notmore...
  • November 14, 2011
    RALEIGH, N.C.--Some ag student out there has a big idea about how to promote ag. The Reach Teach Learn Project will make it happen. Hundreds of youth study on ag college campuses every day, passionate about agriculture and ready to tell their story. The Reach Teach Learn Project provides a vehicle for students to channel that passion into advocacy for agriculture. In its fourth year, the Reach Teach Learn Project—sponsored by Pfizermore...
  • November 7, 2011
    The benefits of in ovo vaccination are now within the reach of many more hatcheries worldwide, thanks to the development of a new compact device. Embrex* Inovoject* m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject. The new device allows thesemore...
  • October 13, 2011
    MADISON, N.J.--Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and othermore...
  • June 8, 2011
    Madison, N.J.--Pfizer Inc.’s Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitroâ (Roxarsone), a feed medicine used primarily in poultry production. Pfizer is taking this action in response to a request by the U.S. Food and Drug Administration (FDA) based on a recent study by the Agency. This study used a new method of testing for very low levels of inorganic arsenic in poultry tissue. The study found that themore...